Cochrane Abstracts
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery New
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Impact of Residual Disease as a Prognostic Factor for Survival in Women With Advanced Epithelial Ovarian Cancer After Primary Surgery New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery_New. Accessed 03 February 2023.
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery_New. Accessed February 3, 2023.
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery_New
Impact of Residual Disease as a Prognostic Factor for Survival in Women With Advanced Epithelial Ovarian Cancer After Primary Surgery New [Internet]. In: Cochrane Abstracts. [cited 2023 February 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery New
ID - 432048
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery_New
DB - Evidence Central
DP - Unbound Medicine
ER -
